Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
2.
Eval Health Prof ; 44(1): 98-101, 2021 03.
Article in English | MEDLINE | ID: covidwho-1102293

ABSTRACT

A single undiagnosed COVID-19 positive patient admitted in the green zone has the potential to infect many Health Care Workers (HCWs) and other patients at any given time with resultant spread of infection and reduction in the available workforce. Despite the existing triaging strategy at the Obstetric unit of a tertiary hospital in New Delhi, where all COVID-19 suspects obstetric patients were tested and admitted in orange zone and non-suspects in green zone, asymptomatic COVID-19 positive patients were found admitted in the green zone. This was the trigger to undertake a quality improvement (QI) initiative to prevent the admission of asymptomatic COVID-19 positive patients in green zones. The QI project aimed at reducing the admission of COVID-19 positive patients in the green zone of the unit from 20% to 10% in 4 weeks' time starting 13/6/2020 by means of dynamic triaging. A COVID-19 action team was made and after an initial analysis of the problem multiple Plan-Do-Study-Act (PDSA) cycles were run to test the change ideas. The main change ideas were revised testing strategies and creating gray Zones for patients awaiting COVID-19 test results. The admission of unsuspected COVID-19 positive cases in the green zone of the unit reduced from 20% to 0% during the stipulated period. There was a significant reduction in the number of HCWs, posted in the green zone, being quarantined or test positive for COVID-19 infection as well. The authors conclude that Quality Improvement methods have the potential to develop effective strategies to prevent spread of the deadly Corona virus.


Subject(s)
COVID-19/prevention & control , Communicable Disease Control/organization & administration , Obstetrics/organization & administration , Quality Improvement/organization & administration , Triage/organization & administration , COVID-19/diagnosis , Humans , India/epidemiology , Mass Screening/organization & administration , SARS-CoV-2 , Tertiary Care Centers/organization & administration
3.
Clin Lab ; 67(1)2021 Jan 01.
Article in English | MEDLINE | ID: covidwho-1045292

ABSTRACT

BACKGROUND: The COVID-19 outbreak, which began in late 2019, continues to ravage the globe and has become the greatest threat to human health. As nucleic acid test is the primary means of screening for COVID-19, this makes the laboratory the most important node in the epidemic prevention and control system. METHODS: As a small laboratory in the hospital, we can meet a large number of demands for nucleic acid test by optimizing staff process, strictly disinfecting experimental batches and changing experimental methods. RESULTS: Through the improvement of the above aspects, our daily maximum detection quantity has been increased from 256/day to 1,012/day. Besides, none of the medical staff has been infected. And there have been no nosocomial infections. CONCLUSIONS: Nucleic acid laboratories, especially small laboratories, should promptly adjust their strategies in the face of unexpected outbreaks and conduct risk assessment in accordance with laboratory activities.


Subject(s)
COVID-19 Nucleic Acid Testing , COVID-19/diagnosis , COVID-19/virology , Health Services Needs and Demand/organization & administration , Mass Screening/organization & administration , Specimen Handling , Workflow , Workload , Humans , Infection Control/organization & administration , Occupational Health , Predictive Value of Tests
4.
Am J Trop Med Hyg ; 104(3_Suppl): 3-11, 2021 Jan 06.
Article in English | MEDLINE | ID: covidwho-1013477

ABSTRACT

Effective identification and prognostication of severe COVID-19 patients presenting to healthcare facilities are essential to reducing morbidity and mortality. Low- and middle-income country (LMIC) facilities often suffer from restrictions in availability of human resources, laboratory testing, medications, and imaging during routine functioning, and such shortages may worsen during times of surge. Low- and middle-income country healthcare providers will need contextually appropriate tools to identify and triage potential COVID-19 patients. We report on a series of LMIC-appropriate recommendations and suggestions for screening and triage of COVID-19 patients in LMICs, based on a pragmatic, experience-based appraisal of existing literature. We recommend that all patients be screened upon first contact with the healthcare system using a locally approved questionnaire to identify individuals who have suspected or confirmed COVID-19. We suggest that primary screening tools used to identify individuals who have suspected or confirmed COVID-19 include a broad range of signs and symptoms based on standard case definitions of COVID-19 disease. We recommend that screening include endemic febrile illness per routine protocols upon presentation to a healthcare facility. We recommend that, following screening and implementation of appropriate universal source control measures, suspected COVID-19 patients be triaged with a triage tool appropriate for the setting. We recommend a standardized severity score based on the WHO COVID-19 disease definitions be assigned to all suspected and confirmed COVID-19 patients before their disposition from the emergency unit. We suggest against using diagnostic imaging to improve triage of reverse transcriptase (RT)-PCR-confirmed COVID-19 patients, unless a patient has worsening respiratory status. We suggest against the use of point-of-care lung ultrasound to improve triage of RT-PCR-confirmed COVID-19 patients. We suggest the use of diagnostic imaging to improve sensitivity of appropriate triage in suspected COVID-19 patients who are RT-PCR negative but have moderate to severe symptoms and are suspected of a false-negative RT-PCR with high risk of disease progression. We suggest the use of diagnostic imaging to improve sensitivity of appropriate triage in suspected COVID-19 patients with moderate or severe clinical features who are without access to RT-PCR testing for SARS-CoV-2.


Subject(s)
COVID-19 Testing/methods , COVID-19/diagnosis , Developing Countries , Mass Screening/methods , Practice Guidelines as Topic , Triage/methods , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Testing/standards , Emergency Service, Hospital , Humans , Mass Screening/organization & administration , Mass Screening/standards , Triage/organization & administration
7.
Eval Health Prof ; 44(1): 93-97, 2021 03.
Article in English | MEDLINE | ID: covidwho-934198

ABSTRACT

Novel coronavirus disease 2019 (COVID-19) was present in most provinces of China after January 2020. We implemented a surveillance and screening strategy that included early detection of laboratory-confirmed COVID-19 cases and people who were exposed to the disease in Guangming District of Shenzhen. Separate targeted treatment and management strategies were applied to confirmed and suspected cases. From January 23 to March 13, 2020, we found 12 suspected cases, and 11 were confirmed as positive. Although eight of the 11 confirmed cases were family-aggregated, they were all imported cases with common exposure, which did not further cause local community transmission, and no medical staff were infected. After February 14, when the last case was confirmed, there were no newly confirmed cases for 28 consecutive days under the strict outbreak control. The targeted and whole-society involved prevention and control measures prevented the spread of the disease in a very short time and provided a strong guarantee for the orderly recovery of returning to work and social activities.


Subject(s)
COVID-19/prevention & control , Communicable Disease Control/organization & administration , China/epidemiology , Community Health Services/organization & administration , Humans , Mass Screening/organization & administration , SARS-CoV-2 , Time Factors
10.
J Diabetes Res ; 2020: 9036847, 2020.
Article in English | MEDLINE | ID: covidwho-894922

ABSTRACT

Recently, telemedicine has become remarkably important, due to increased deployment and development of digital technologies. National and international guidelines should consider its inclusion in their updates. During the COVID-19 pandemic, mandatory social distancing and the lack of effective treatments has made telemedicine the safest interactive system between patients, both infected and uninfected, and clinicians. A few potential evidence-based scenarios for the application of telemedicine have been hypothesized. In particular, its use in diabetes and complication monitoring has been remarkably increasing, due to the high risk of poor prognosis. New evidence and technological improvements in telemedicine application in diabetic retinopathy (DR) have demonstrated efficacy and usefulness in screening. Moreover, despite an initial increase for devices and training costs, teleophthalmology demonstrated a good cost-to-efficacy ratio; however, no national screening program has yet focused on DR prevention and diagnosis. Lack of data during the COVID-19 pandemic strongly limits the possibility of tracing the real management of the disease, which is only conceivable from past evidence in normal conditions. The pandemic further stressed the importance of remote monitoring. However, the deployment of device and digital application used to increase screening of individuals and monitor progression of retinal disease needs to be easily accessible to general practitioners.


Subject(s)
Coronavirus Infections/epidemiology , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/therapy , Pandemics , Pneumonia, Viral/epidemiology , Telemedicine , Betacoronavirus/physiology , COVID-19 , Cost-Benefit Analysis , Diabetic Retinopathy/epidemiology , Humans , Mass Screening/economics , Mass Screening/methods , Mass Screening/organization & administration , Mass Screening/trends , Ophthalmology/economics , Ophthalmology/methods , Ophthalmology/organization & administration , Ophthalmology/trends , SARS-CoV-2 , Telemedicine/economics , Telemedicine/organization & administration , Telemedicine/standards , Telemedicine/trends
11.
Acta Otorhinolaryngol Ital ; 40(5): 325-331, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-792798

ABSTRACT

OBJECTIVE: The aim of this study was to provide an accurate picture of the changes which have occurred during the COVID-19 pandemic, and the contributions given by Italian Otolaryngology Units. METHODS: A 29-item questionnaire was completed and returned by 154 Otorhinolaryngology Units across Italy that investigated geographic distribution, the main changes which occurred in workload management and in clinical and surgical activities and screening procedures for COVID-19 in healthcare personnel and patients. RESULTS: Nearly half of the Otolaryngology Units that responded to the questionnaire were merged with other units, while 22% were converted into COVID-19 units or temporarily closed. A reduction of 8.55% in the number of team members was reported, and about 50% of the units applied uniform work shifts for all staff. Elective activities were uniformly stopped or delayed, passing from 30,295 (pre-COVID data) to 5,684 (COVID data) weekly procedures, with a mean decrease of 81.24% (p < 0.001). CONCLUSIONS: Most of the elective otolaryngology activities were suspended during the pandemic; the only procedures were for oncology and emergency patients. Italian Otolaryngologists have demonstrated a high availability to collaborate with non-surgical colleagues.


Subject(s)
COVID-19/epidemiology , Infection Control/organization & administration , Otolaryngology , Practice Patterns, Physicians'/statistics & numerical data , COVID-19/diagnosis , Humans , Italy/epidemiology , Mass Screening/organization & administration , Pandemics , Personnel Staffing and Scheduling/trends , SARS-CoV-2 , Surveys and Questionnaires , Workload
12.
Int J Environ Res Public Health ; 17(18)2020 09 04.
Article in English | MEDLINE | ID: covidwho-750686

ABSTRACT

Keeping the dynamic nature of Coronaviruses (COVID-19) pandemic in mind, we have opted to explore the importance of the decentralization of COVID-19 testing centers across the country of Bangladesh in order to combat the pandemic. In doing so, we considered quantitative, qualitative, and geographic information systems (GIS) datasets to identify the location of existing COVID-19 testing centers. Moreover, we attempted to collect data from the existing centers in order to demonstrate testing times at the divisional level of the country. Results show that the number of testing centers is not enough to cater to the vast population of the country. Additionally, we found that the number of days it takes to receive the results from the COVID-19 testing centers is not optimal at divisional cities, let alone the remote rural areas. Finally, we propose a set of recommendations in order to enhance the existing system to assist more people under a testing range of COVID-19 viruses at the local level.


Subject(s)
Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Mass Screening/organization & administration , Pneumonia, Viral/diagnosis , Bangladesh/epidemiology , Betacoronavirus , COVID-19 , COVID-19 Testing , Geographic Information Systems , Humans , Pandemics , SARS-CoV-2
13.
Emerg Med Australas ; 32(5): 809-813, 2020 10.
Article in English | MEDLINE | ID: covidwho-733269

ABSTRACT

OBJECTIVE: Early during the coronavirus disease 2019 (COVID-19) pandemic, Australian EDs experienced an unprecedented surge in patients seeking screening. Understanding what proportion of these patients require testing and who can be safely screened in community-based models of care is critical for workforce and infrastructure planning across the healthcare system, as well as public messaging campaigns. METHODS: In this cross-sectional survey, we screened patients presenting to a COVID-19 screening clinic in a tertiary ED. We assessed the proportion of patients who met testing criteria; self-reported symptom severity; reasons why they came to the ED for screening and views on community-based care. RESULTS: We include findings from 1846 patients. Most patients (55.3%) did not meet contemporaneous criteria for testing and most (57.6%) had mild or no (13.4%) symptoms. The main reason for coming to the ED was being referred by a telephone health service (31.3%) and 136 (7.4%) said they tried to contact their general practitioner but could not get an appointment. Only 47 (2.6%) said they thought the disease was too specialised for their general practitioner to manage. CONCLUSIONS: While capacity building in acute care facilities is an important part of pandemic planning, it is also important that patients not needing hospital level of care can be assessed and treated elsewhere. We have identified a significant proportion of people at this early stage in the pandemic who have sought healthcare at hospital but who might have been assisted in the community had services been available and public health messaging structured to guide them there.


Subject(s)
Coronavirus Infections/diagnosis , Health Services Accessibility/statistics & numerical data , Mass Screening/organization & administration , Pandemics/statistics & numerical data , Patient Preference , Pneumonia, Viral/diagnosis , Ambulatory Care Facilities/statistics & numerical data , Australia , COVID-19 , Coronavirus Infections/epidemiology , Cross-Sectional Studies , Emergency Service, Hospital/statistics & numerical data , Female , Humans , Incidence , Male , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Public Health , Risk Assessment , Tertiary Care Centers
15.
Int J Mol Sci ; 21(12)2020 Jun 22.
Article in English | MEDLINE | ID: covidwho-705276

ABSTRACT

Our work concerns the actual problem of spread of SARS- CoV-2 outbreak which requires fast and correct as possible answer. In current scenario, the need of rapid answer put away the imperative of proper methodology. We focus on the serogical immunoassay for diagnosis of Covid-19 as an important weapon not only for diagnostic purpose, but also for epidemiologic one. The right equilibrium between high speed, low cost and accuracy is obtained with easy-to-use decentralized point-of-care test as the colloidal gold-based immunochromatographic strip assay which detects IgM and IgG antibodies directed against SARS-CoV-2. As our aim is to evaluate the efficacy of Covid-19 rapid tests and of serological assays in real-life settings, we designed a research protocol aimed to establish how to use correctly these diagnostics, taking into account the different possible clinical and epidemiological scenarios.


Subject(s)
Clinical Laboratory Techniques/methods , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques/standards , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Humans , Mass Screening/methods , Mass Screening/organization & administration , Mass Screening/standards , Pneumonia, Viral/epidemiology , Practice Guidelines as Topic , Primary Prevention/methods , Primary Prevention/organization & administration , Primary Prevention/standards
17.
Clin Med (Lond) ; 20(5): e165-e169, 2020 09.
Article in English | MEDLINE | ID: covidwho-652106

ABSTRACT

We describe the London community testing programme developed for COVID-19, audit its effectiveness and report patient acceptability and patient adherence to isolation guidance, based upon a survey conducted with participants.Any patients meeting the Public Health England (PHE) case definition for COVID-19 who did not require hospital admission were eligible for community testing. 2,053 patients with suspected COVID-19 were tested in the community between January and March 2020. Of those tested, 75 (3.6%) were positive. 88% of patients that completed a patient survey felt safe and 82% agreed that community testing was preferable to hospital admission. 97% were able to remain within their own home during the isolation period but just 41% were able to reliably isolate from other members of their household.The London community testing programme allowed widespread testing for COVID-19 while minimising patient transport, hospital admissions and staff exposures. Community testing was acceptable to patients and preferable to admission to hospital. Patients were able to reliably isolate in their home but not from household contacts. The authors believe in the importance, feasibility and acceptability of community testing for COVID-19 as a part of a package of interventions to mitigate a second wave of infection.


Subject(s)
Clinical Laboratory Techniques/statistics & numerical data , Community Health Services/organization & administration , Coronavirus Infections/diagnosis , Mass Screening/organization & administration , Patient Compliance/statistics & numerical data , Pneumonia, Viral/diagnosis , COVID-19 , COVID-19 Testing , Coronavirus Infections/epidemiology , Cross-Sectional Studies , England , Female , Humans , London , Male , Pandemics , Pneumonia, Viral/epidemiology , Program Development , Program Evaluation , Public Health
19.
Disaster Med Public Health Prep ; 15(3): e37-e42, 2021 06.
Article in English | MEDLINE | ID: covidwho-647029

ABSTRACT

Coronavirus disease 2019 (COVID-19), first documented in December 2019, was declared a public health emergency by the World Health Organization (WHO) on January 30, 2020 (https://www.who.int/westernpacific/emergencies/covid-19). The disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has affected more than 9 million people and contributed to at least 490,000 deaths globally as of June 2020, with numbers on the rise (https://www.worldometers.info/coronavirus/#countries).Increased numbers of patients seeking medical attention during disease outbreaks can overwhelm healthcare facilities, hence requiring an equivalent response from healthcare services. Surge capacity is a concept that has not only been defined as the "ability to respond to a sudden increase in patient care demands" (Hick et al., Disaster Med Public Health Prep. 2008;2:S51-S57) but also to "effectively and rapidly expand capacity" (Watson et al., Milbank Q. 2013;91(1):78-122).This narrative review discusses how Singapore's largest tertiary hospital has encapsulated the elements of surge capability and transformed a peacetime multi-story carpark into a flu screening area in response to the COVID-19 disease outbreak.


Subject(s)
COVID-19/diagnosis , COVID-19/epidemiology , Mass Screening/organization & administration , Surge Capacity/organization & administration , Tertiary Care Centers/organization & administration , Disease Outbreaks , Humans , Pandemics , SARS-CoV-2 , Singapore/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL